Open Tender for Ustekinumab solution for Intravenous infusion stelara 130 mg 26 ml,Ustekinumab solution for Subcuta in PUNE, MAHARASHTRA

The eligibility requirements include being a registered entity with the necessary pharmaceutical certifications, demonstrating experience in supplying similar pharmaceutical products, and compliance with local governmental regulations applicable to pharmaceutical supplies.

Bid submissions must include technical certificates for Ustekinumab solutions and the Recombinant Factor VIII products, compliance with quality standards such as ISO, and proof of adherence to Good Manufacturing Practices (GMP).

To register for this tender, bidders must create an account on the designated procurement portal. Accepted document formats for submission are PDF and Word files. It is important to ensure all documents are complete and compliant with the tender specifications.

The Earnest Money Deposit (EMD) amount is specified in the tender documentation and serves as a commitment from the bidders. Additionally, successful bidders will be required to submit a performance security, typically a percentage of the contract value, to ensure fulfillment of the contract terms.

The evaluation process will assess both technical and financial aspects of the bids. Factors such as compliance with technical standards, competitive pricing, and supplier reliability and past performance will be critical in determining the winning bid. Notifications of results will be communicated through official channels as specified in the documentation.